24/7 Market News Snapshot 14 Jun 2024 – OneMedNet Corp Class A Common Stock (NASDAQ: ONMD)

June 14, 2024 7:51

Press Release

DENVER, Colo., 14 June, 2024 (247marketnews.com) – (Nasdaq:ONMD) are discussed in this article.
OneMedNet Corporation (Nasdaq:ONMD) is making headlines with a remarkable surge in pre-market trading, soaring to $1.514 from the previous closing price of $1.215. Boasting a substantial trading volume of 1.3 million, the stock has surged by an impressive 24.61% at the market’s opening. This surge reflects a robust investor interest in ONMD, hinting at further growth potential. Market analysts are optimistic about the technical indicators, forecasting a promising trajectory for ONMD and highlighting it as a stock to closely monitor for potential investment opportunities.

In another significant development, OneMedNet has forged a pioneering partnership with a leading global player in clinical trial solutions. This strategic collaboration, marked by the iRWD™ Customer Data License Agreement, grants the partner access to OneMedNet’s extensive repository of high-quality Real World Data (RWD). By leveraging this unparalleled data resource, the partnership aims to revolutionize real-world evidence utilization in optimizing clinical trials, fueling medical breakthroughs, and expediting therapeutic innovation.

Commenting on the partnership, a spokesperson from OneMedNet expressed enthusiasm for the transformative potential of the collaboration, emphasizing the shared vision to enhance data-driven decision-making processes and catalyze advancements in healthcare research. This milestone alliance underscores OneMedNet’s commitment to driving precision medicine and reinforcing research endeavors with robust RWD solutions.

As stakeholders eagerly anticipate the collaborative impact of this partnership, the industry is poised for a new era of data-driven innovation in healthcare and clinical research. The synergy between OneMedNet and its clinical trial solutions partner is set to redefine industry benchmarks, unlocking unprecedented opportunities for advancements in medical science. With both the stock surge and the groundbreaking partnership making waves, the future looks promising for ONMD and its endeavors at the forefront of healthcare innovation.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 Market News, Inc Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.